TY - JOUR
T1 - Endocrinopathies from checkpoint inhibitors
T2 - Incidence, outcomes, and management
AU - Kennedy, Randol
AU - Awada, Hussein
AU - Vura, Naga
AU - Ciltea, Daniela
AU - Morocco, Michael
N1 - Publisher Copyright:
© 2023, Cleveland Clinic Journal of Medicine.All Rights Reserved.
PY - 2023/5
Y1 - 2023/5
N2 - Immune checkpoint inhibitors are used more and more to treat several types of cancer, signifi cantly extending cancer-free survival. However, concerns are growing about their toxic effects, which are many and varied. Endocrinopathies are some of the most frequently reported adverse effects, and thyroid dysfunction is the most common of these.
AB - Immune checkpoint inhibitors are used more and more to treat several types of cancer, signifi cantly extending cancer-free survival. However, concerns are growing about their toxic effects, which are many and varied. Endocrinopathies are some of the most frequently reported adverse effects, and thyroid dysfunction is the most common of these.
UR - http://www.scopus.com/inward/record.url?scp=85158038399&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85158038399&partnerID=8YFLogxK
U2 - 10.3949/ccjm.90a.22032
DO - 10.3949/ccjm.90a.22032
M3 - Review article
C2 - 37127339
AN - SCOPUS:85158038399
SN - 0891-1150
VL - 90
SP - 307
EP - 317
JO - Cleveland Clinic journal of medicine
JF - Cleveland Clinic journal of medicine
IS - 5
ER -